Mesoporous Nano-Magnesium Oxide for Drug Loading
Summary
The USPTO has published a patent application for a mesoporous nano-magnesium oxide material designed for drug loading. The application details the material's properties, including particle size and pore structure, and outlines a preparation method involving magnesium oxalate and CTAB.
What changed
This document is a USPTO patent application (US20260083680A1) for a novel mesoporous nano-magnesium oxide material intended for drug loading. The application specifies particle size (50-150 nm), pore size (2-20 nm), and a positive Zeta potential in absolute ethanol. It also describes a preparation method involving calcining magnesium oxalate and CTAB at specific temperatures.
As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it may inform future research and development in drug delivery systems. Companies in the pharmaceutical sector may wish to review this application for potential intellectual property insights or to understand emerging technologies in drug formulation and delivery.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MESOPOROUS NANO-MAGNESIUM OXIDE FOR DRUG LOADING AND PREPARATION METHOD THEREOF
Application US20260083680A1 Kind: A1 Mar 26, 2026
Assignee
SHANGHAI INSTITUTE OF TECHNOLOGY
Inventors
Chun XU
Abstract
A mesoporous nano-magnesium oxide for drug loading and a preparation method thereof are provided. The mesoporous nano-magnesium oxide particle has a particle size of 50 nm to 150 nm, and includes abundant mesoporous structures with a pore size of 2 nm to 20 nm. A surface of the particle has a positive potential in absolute ethanol, with a Zeta potential distribution of 10 mV to 100 mV. The preparation method includes: preparing a mixture of magnesium oxalate and CTAB as a precursor; adding the precursor to a quartz crucible, and placing the quartz crucible in a muffle furnace; calcining at 200℃ for 1 h to make the CTAB in the mixture completely decomposed to produce pure magnesium oxalate; and heating to 530°C, and calcining for 1 h to 6 h to make the magnesium oxalate fully decomposed to produce the nano-magnesium oxide microparticle.
CPC Classifications
A61K 9/5115 A61K 9/5192
Filing Date
2025-08-18
Application No.
19302131
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.